| Followed By | 25 |
| Posts | 9937 |
| Boards Moderated | 0 |
| Alias Born | 02/26/2016 |
- H.C. Wainwright Reaffirms Their Buy Rating on Anavex Life Sciences (AVXL) • TipRanks • 05/20/2022 10:25:46 AM
- Anavex Life Sciences to Present at the H. C. Wainwright Global Investment Conference 2022 • GlobeNewswire Inc. • 05/19/2022 11:00:00 AM
- Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL) and OncoCyte (OCX) • TipRanks • 05/12/2022 07:39:47 AM
- Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 Second Quarter Financial Results • GlobeNewswire Inc. • 05/10/2022 11:00:00 AM
- Anavex Life Sciences to Announce Fiscal 2022 Second Quarter Financial Results on Tuesday May 10, 2022 • GlobeNewswire Inc. • 05/03/2022 11:00:00 AM
- Anavex Life Sciences Announces Presentations at the IRSF Rett Syndrome Scientific Meeting • GlobeNewswire Inc. • 04/27/2022 11:00:00 AM
- Anavex Life Sciences Invited to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference • GlobeNewswire Inc. • 04/26/2022 11:00:00 AM
- The Next Catalyst Events at Trending Growth Companies and This Week's Feature Report • InvestorsHub NewsWire • 04/19/2022 12:30:00 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 04/11/2022 09:16:05 PM
- Proxy Statement (definitive) (def 14a) • Edgar (US Regulatory) • 04/11/2022 09:09:24 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 04/08/2022 08:31:13 PM
- Anavex Life Sciences to Present at the Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2022 11:00:00 AM
- Anavex Life Sciences to Participate in the Cantor Virtual Rare Orphan Disease Summit • GlobeNewswire Inc. • 03/28/2022 11:00:00 AM
- H.C. Wainwright Thinks Anavex Life Sciences’ Stock is Going to Recover • TipRanks • 03/16/2022 10:19:26 AM
- Anavex posts mid-stage biomarker data for lead candidate • Seeking Alpha • 03/15/2022 12:19:10 PM
- Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from ANAVEX®2-73-PDD-001 Parkinson’s Disease Dementia Study at AD/PD™ 2022 International Conference • GlobeNewswire Inc. • 03/15/2022 11:00:00 AM
- Anavex Life Sciences to Participate in the Annual Needham Virtual Neuroscience Forum • GlobeNewswire Inc. • 03/09/2022 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/04/2022 12:01:24 PM
- Anavex Life Sciences Announces Change of Auditor to Grant Thornton LLP • GlobeNewswire Inc. • 03/04/2022 12:00:00 PM
- Biopharma Companies Setting up for a Rebound in the Near Term and a New Blockchain Feature Report • InvestorsHub NewsWire • 02/16/2022 01:00:00 PM
- Anavex CEO addresses Rett syndrome drug data controversy in quarterly call • Seeking Alpha • 02/10/2022 02:17:44 PM
- Anavex Life Sciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference • GlobeNewswire Inc. • 02/10/2022 12:00:00 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/09/2022 10:17:28 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/09/2022 08:27:30 PM
- Anavex Life Sciences GAAP EPS of -$0.14 • Seeking Alpha • 02/09/2022 12:20:23 PM
KINETIC Group (OTC:KNIT) ("KNIT") Acquires GSS Infrastructure LLC in an All Stock Transaction • KNIT • May 27, 2022 10:00 AM
XCPCNL Signs Letter of Intent to Acquire Communications, Financial Disclosure, and Multimedia Marketing Firm, Mcap Media, Inc. • XCPL • May 27, 2022 7:00 AM
Thunder Energies Signs $40 Million Funding Agreement • TNRG • May 26, 2022 4:30 PM
Emerging Markets Report: A Case for Uranium • LAM • May 26, 2022 10:07 AM
HNRC UPDATES ON SECOND $100 MILLION DOLLAR SPAC • HNRC • May 26, 2022 10:00 AM
Grove Inc. Upexi Division Launches Medicinal Mushroom Product Line Direct to Consumer and on Amazon • GRVI • May 26, 2022 9:07 AM
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome • SPRC • May 26, 2022 8:35 AM
Branded Legacy, Inc. Signs LOI To Acquire First Patent Thomas Pepper Johnson To Join Company's Executive Team • BLEG • May 26, 2022 8:30 AM
Dalrada Continues Upward Trajectory with 252% Growth in Third Quarter 2022 Financial Results • DFCO • May 26, 2022 8:00 AM
Atlanta Based Specialty Realty Group Reorganizes, Changes Business Plan & Leadership • TNRG • May 25, 2022 8:00 PM
OTC: ILUS, ILUS International (Ilustrato Pictures International Inc) Agrees Terms With an Acquisition Delivering Upwards of $100 Million in Annual Revenue • ILUS • May 25, 2022 11:52 AM
Branded Legacy, Inc. To Introduce New Delta 9 blend THC-0/Delta-8 Blend Gummies Sell Out Again • BLEG • May 25, 2022 8:30 AM
Goldshore Resources Announces Public (NSERC & MITACS) and Educational (Lakehead University) Tri-Party Institutional Partnership with Alliance Grant • GSHR • May 25, 2022 8:20 AM
Ultrack Systems Fully Acquires California Trucking Company M-Loan Inc. • MJLB • May 24, 2022 9:30 AM
SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment • CMND • May 24, 2022 8:36 AM
| Volume: | |
| Day Range: | |
| Bid: | |
| Ask: | |
| Last Trade Time: | |
| Total Trades: |
- 1D
- 1M
- 2M
- 3M
- 6M
- 1Y
- 2Y
- 3Y
- 5Y
Follow Board